The pharmaceutical industry has been globalizing for many years as demand for medicinal products grows and as companies look to expand into the large and increasingly prosperous emerging markets. The impact of rapid globalization is that the industry is dealing with complex and ever-changing regulations and government policies that can vary across jurisdictions. The podcast explores the opportunities and challenges of globalization.

Bio: Dr. Jürgen Hönig is Senior Director, Regulatory Business Intelligence, where he participates in the design of regulatory affairs strategy, analyzes trends in the pharmaceutical and regulatory devices industries and supports the interface between regulatory affairs and marketing and sales. Jürgen has been in the pharmaceutical industry for nearly 25 years and previously was a pharmacist. He has a Ph.D. and an undergraduate degree in pharmacy.

0 Comments Sort By